Asthma Patients Treated Safely with Salmeterol-Fluticasone Combo

An FDA-mandated study finds use of LABA plus ICS in a single inhaler noninferior to ICS alone with regard to serious asthma outcomes.

Source: ConsultantLive - May 9, 2016 Category: Internal Medicine Authors: Mark L. Fuerst Tags: Asthma Source Type: news